To investigate the metabolite signatures of ME/CFS patient stool, urine and blood samples and the impact that co-morbidities (IBS and Fibromyalgia) have on these signatures.
ME/CFS patients often suffer from multiple comorbidities. When observing a cohort of ME/CFS patients we often neglect to consider the impact that co-morbidities are having on the biological signatures produced that might be distinct from ME/CFS alone. In this study we look at ME/CFS patients with and without IBS and Fibromyalgia to determine the impact of these comorbidities.
We expect their impact will highlight the importance of matching for co-morbidities when conducting case-control studies.